Finance

Lists
URGN:NASDAQ
Urogen Pharma Ltd
36,40 $
-0,48%
(-0,18) 1D
15 қаз., 15:09:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for URGN...
Open
37,04 $
High
38,37 $
Low
36,27 $
Mkt. cap
1,78 млрд
Avg. vol.
903,86 м.
Volume
236,66 м.
52-wk high
50,81 $
52-wk low
16,36 $
EPS
-1,98 $
Beta
1,57
Shares outstanding
48,88 млн
No. of employees
300
Open
37,04 $
High
38,37 $
Low
36,27 $
Mkt. cap
1,78 млрд
Avg. vol.
903,86 м.
Volume
236,66 м.
52-wk high
50,81 $
52-wk low
16,36 $
EPS
-1,98 $
Beta
1,57
Shares outstanding
48,88 млн
No. of employees
300
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
7 сағат бұрын
MarketBeat cites USD 52.38 target for UroGen Pharma stock
Stock Traders Daily
Stock Traders Daily
·
1 күн бұрын
(URGN) Risk Channels and Responsive Allocation
About Urogen Pharma Ltd
CEO-
Employees300
Founded2004
HeadquartersНью-Йорк, Нью-Йорк, Америка Құрама Штаттары
Sector-
Websiteurogen.com
Analyst ratings
Based on 5 analysts giving stock ratings to URGN in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for URGN in the last 3 months.
Highest
Current 36,40 $
75,00 $ (+106,02%)
Average
60,20 $ (+65,36%)
Lowest
48,00 $ (+31,85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
75,00 $
+106%
08/21/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
60,00 $
+64,8%
08/06/2026
Paul Choi
Goldman Sachs
Hold
Maintained
48,00 $
+31,9%
08/05/2026
Michael Schmidt
Guggenheim
Buy
Maintained
58,00 $
+59,3%
08/05/2026
Tara Bancroft
TD Cowen
Buy
Reiterated
60,00 $
+64,8%
08/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
32,00 $
-12,1%
06/03/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
43,00 $
+18,1%
05/11/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
40,00 $
+9,9%
04/20/2026
Amin Makarem
Jefferies
Buy
Initiated
40,00 $
+9,9%
04/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
27,48 млн
37,84 млн
50,96 млн
72,46 млн
Cost of goods sold
3,28 млн
3,29 млн
4,14 млн
6,57 млн
Cost of revenue
3,28 млн
3,29 млн
4,14 млн
6,57 млн
Research and development expenses
14,01 млн
14,31 млн
15,60 млн
17,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,58 млн
39,35 млн
51,49 млн
48,44 млн
Operating expense
51,59 млн
53,66 млн
67,08 млн
65,77 млн
Total operating expenses
54,87 млн
56,95 млн
71,22 млн
72,34 млн
Operating income
-27,39 млн
-19,12 млн
-20,26 млн
111,00 м.
Other non operating income
-4,82 млн
-4,66 млн
-4,83 млн
-4,89 млн
EBT including unusual items
-34,40 млн
-26,64 млн
-28,35 млн
-8,72 млн
EBT excluding unusual items
-34,40 млн
-26,64 млн
-28,35 млн
-8,72 млн
Income tax expense
-1,05 млн
-275,00 м.
-4,77 млн
5,63 млн
Effective tax rate
3,06%
1,03%
16,83%
-64,54%
Other operating expenses
-
-
-
-
Net income
-33,35 млн
-26,36 млн
-23,57 млн
-14,35 млн
Net profit margin
-121,34%
-69,68%
-46,26%
-19,81%
Earnings per share
-0,69
-0,53
-0,47
-0,28
Interest and investment income
1,18 млн
908,00 м.
931,00 м.
946,00 м.
Interest expense
-3,37 млн
-3,77 млн
-4,18 млн
-4,89 млн
Net interest expenses
-2,20 млн
-2,86 млн
-3,25 млн
-3,94 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,31 млн
-19,04 млн
-20,19 млн
189,00 м.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары